PLOS ONE Medicine&Health

Serum 25(OH)D levels and mortality risk among middle-aged and elderly populations in the U.S.: A prospective cohort study

by Yaowen Hu, Faliang Gao, Yuan Yang, Wei Yang, Huibo He, Jie Zhou, Yujie Zhao, Xi Chen, Wenyan Zhao, Xiaopeng He

To investigate the prevalence of vitamin D deficiency and its relationship with all-cause and cause-specific mortality among middle-aged and elderly populations in the U.S.

Data were sourced from the National Health and Nutrition Examination Survey (NHANES) 2001–2018. A total of 22,130 participants aged 40–70 years were included. Serum 25-hydroxy vitamin D [25(OH)D] concentrations were measured and categorized. The primary outcome was all-cause mortality, and secondary outcomes were cardiovascular disease (CVD) and cancer mortality. Multivariable-adjusted models and various statistical analyses were employed.

The prevalence of vitamin D deficiency (≤50.00 nmol/L) was 33.59%, and insufficiency (≤75.00 nmol/L) was 71.74%. For all-cause mortality, the multivariate adjusted hazard ratios (HRs) across different 25(OH)D levels (p = 0.0069, 0.59 (0.49,0.72) p p  Conclusion

This study found that higher serum 25-hydroxyvitamin D concentrations are linked to lower all-cause, cardiovascular, and cancer mortality. The relationship is nonlinear: increases in concentration reduce death risk below a certain threshold, but above it, the association weakens. Further research is needed to understand causal mechanisms.